vs

Side-by-side financial comparison of Finwise Bancorp (FINW) and FONAR CORP (FONR). Click either name above to swap in a different company.

Finwise Bancorp is the larger business by last-quarter revenue ($42.7M vs $25.5M, roughly 1.7× FONAR CORP). FONAR CORP runs the higher net margin — 8.0% vs 6.4%, a 1.6% gap on every dollar of revenue. Over the past eight quarters, Finwise Bancorp's revenue compounded faster (47.0% CAGR vs -0.3%).

Finwise Bancorp is a U.S.-based financial holding company that operates primarily through its community banking subsidiary. It offers a full suite of retail and commercial financial services, including deposit accounts, personal loans, mortgage products, small business financing, and wealth management solutions, serving local retail consumers and small to medium-sized business clients across its regional operating markets.

FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.

FINW vs FONR — Head-to-Head

Bigger by revenue
FINW
FINW
1.7× larger
FINW
$42.7M
$25.5M
FONR
Higher net margin
FONR
FONR
1.6% more per $
FONR
8.0%
6.4%
FINW
Faster 2-yr revenue CAGR
FINW
FINW
Annualised
FINW
47.0%
-0.3%
FONR

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
FINW
FINW
FONR
FONR
Revenue
$42.7M
$25.5M
Net Profit
$2.7M
$2.1M
Gross Margin
Operating Margin
13.5%
Net Margin
6.4%
8.0%
Revenue YoY
2.4%
Net Profit YoY
4.7%
EPS (diluted)
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FINW
FINW
FONR
FONR
Q1 26
$42.7M
Q4 25
$46.9M
$25.5M
Q3 25
$36.7M
$26.0M
Q2 25
$25.1M
$27.3M
Q1 25
$22.1M
$27.2M
Q4 24
$21.1M
$24.9M
Q3 24
$20.8M
$25.0M
Q2 24
$19.8M
$25.9M
Net Profit
FINW
FINW
FONR
FONR
Q1 26
$2.7M
Q4 25
$3.9M
$2.1M
Q3 25
$4.9M
$2.3M
Q2 25
$4.1M
$729.3K
Q1 25
$3.2M
$2.5M
Q4 24
$2.8M
$2.0M
Q3 24
$3.5M
$3.1M
Q2 24
$3.2M
$830.4K
Operating Margin
FINW
FINW
FONR
FONR
Q1 26
Q4 25
11.7%
13.5%
Q3 25
17.5%
14.1%
Q2 25
21.7%
5.3%
Q1 25
20.1%
15.2%
Q4 24
17.5%
11.9%
Q3 24
22.2%
21.0%
Q2 24
21.1%
7.4%
Net Margin
FINW
FINW
FONR
FONR
Q1 26
6.4%
Q4 25
8.4%
8.0%
Q3 25
13.3%
8.7%
Q2 25
16.3%
2.7%
Q1 25
14.4%
9.2%
Q4 24
13.2%
7.9%
Q3 24
16.6%
12.6%
Q2 24
16.1%
3.2%
EPS (diluted)
FINW
FINW
FONR
FONR
Q1 26
$0.20
Q4 25
$0.27
Q3 25
$0.34
Q2 25
$0.29
Q1 25
$0.23
Q4 24
$0.19
Q3 24
$0.25
Q2 24
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FINW
FINW
FONR
FONR
Cash + ST InvestmentsLiquidity on hand
$121.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$196.6M
$176.9M
Total Assets
$899.4M
$217.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FINW
FINW
FONR
FONR
Q1 26
Q4 25
$163.4M
$121.0K
Q3 25
$105.6M
$122.0K
Q2 25
$90.1M
$56.5M
Q1 25
$120.3M
$123.0K
Q4 24
$109.2M
$121.0K
Q3 24
$85.8M
$136.0K
Q2 24
$89.0M
$56.5M
Total Debt
FINW
FINW
FONR
FONR
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$66.9K
Stockholders' Equity
FINW
FINW
FONR
FONR
Q1 26
$196.6M
Q4 25
$193.2M
$176.9M
Q3 25
$187.8M
$174.9M
Q2 25
$182.0M
$172.6M
Q1 25
$177.4M
$171.9M
Q4 24
$173.7M
$169.8M
Q3 24
$170.4M
$168.7M
Q2 24
$165.8M
$166.0M
Total Assets
FINW
FINW
FONR
FONR
Q1 26
$899.4M
Q4 25
$977.1M
$217.2M
Q3 25
$899.9M
$218.4M
Q2 25
$842.5M
$216.9M
Q1 25
$804.1M
$214.9M
Q4 24
$746.0M
$208.0M
Q3 24
$683.0M
$212.3M
Q2 24
$617.8M
$214.2M
Debt / Equity
FINW
FINW
FONR
FONR
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FINW
FINW
FONR
FONR
Operating Cash FlowLast quarter
$171.0K
Free Cash FlowOCF − Capex
$-227.0K
FCF MarginFCF / Revenue
-0.9%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
0.08×
TTM Free Cash FlowTrailing 4 quarters
$5.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FINW
FINW
FONR
FONR
Q1 26
Q4 25
$-28.4M
$171.0K
Q3 25
$3.5M
$1.7M
Q2 25
$-18.3M
$4.2M
Q1 25
$-21.6M
$3.1M
Q4 24
$-15.0M
$2.2M
Q3 24
$-9.8M
$1.7M
Q2 24
$-7.6M
$4.6M
Free Cash Flow
FINW
FINW
FONR
FONR
Q1 26
Q4 25
$-28.6M
$-227.0K
Q3 25
$3.4M
$-177.0K
Q2 25
$-19.8M
$3.6M
Q1 25
$-23.3M
$2.6M
Q4 24
$-16.1M
$1.5M
Q3 24
$-13.4M
$-148.0K
Q2 24
$-7.7M
$4.2M
FCF Margin
FINW
FINW
FONR
FONR
Q1 26
Q4 25
-61.1%
-0.9%
Q3 25
9.4%
-0.7%
Q2 25
-79.0%
13.1%
Q1 25
-105.3%
9.4%
Q4 24
-76.0%
6.0%
Q3 24
-64.3%
-0.6%
Q2 24
-38.7%
16.1%
Capex Intensity
FINW
FINW
FONR
FONR
Q1 26
Q4 25
0.5%
1.6%
Q3 25
0.1%
7.2%
Q2 25
5.8%
2.4%
Q1 25
7.4%
2.2%
Q4 24
5.1%
3.0%
Q3 24
17.2%
7.2%
Q2 24
0.3%
1.6%
Cash Conversion
FINW
FINW
FONR
FONR
Q1 26
Q4 25
-7.26×
0.08×
Q3 25
0.71×
0.75×
Q2 25
-4.48×
5.79×
Q1 25
-6.78×
1.26×
Q4 24
-5.37×
1.14×
Q3 24
-2.84×
0.53×
Q2 24
-2.39×
5.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FINW
FINW

Net Interest Income$28.1M66%
Noninterest Income$14.6M34%

FONR
FONR

Managementof Diagnostic Imaging Centers$23.2M91%
Manufacturingand Servicingof Medical Equipment$2.4M9%

Related Comparisons